Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Teo

Showing results (511-520 of 529) with videos related to

Pageof 53
Sort By:
The New England Journal of Medicine|March 28, 2007
Optimal medical therapy with or without PCI for stable coronary diseaseWilliam E Boden, Robert A O'Rourke, Koon K Teo, et al.
Biochimica Et Biophysica Acta. Biomembranes|June 1, 2019
SMA-PAGE: A new method to examine complexes of membrane proteins using SMALP nano-encapsulation and native gel electrophoresisNaomi L Pollock, Megha Rai, Kailene S Simon, et al.
The American Journal of Clinical Nutrition|May 21, 2020
Association of nut intake with risk factors, cardiovascular disease, and mortality in 16 countries from 5 continents: analysis from the Prospective Urban and Rural Epidemiology (PURE) studyRussell J de Souza, Mahshid Dehghan, Andrew Mente, et al.
Circulation|February 13, 2008
Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudyLeslee J Shaw, Daniel S Berman, David J Maron, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 23, 2016
Reference ranges of handgrip strength from 125,462 healthy adults in 21 countries: a prospective urban rural epidemiologic (PURE) studyDarryl P Leong, Koon K Teo, Sumathy Rangarajan, et al.
Journal of the American College of Cardiology|March 27, 2010
Intensive multifactorial intervention for stable coronary artery disease: optimal medical therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trialDavid J Maron, William E Boden, Robert A O'Rourke, et al.
International Journal of Epidemiology|December 23, 2021
Variations in the association of height with mortality, cardiovascular disease and cancer in low-, middle- and high-income countriesAditya K Khetan, Darryl P Leong, Rajeev Gupta, et al.
Lancet (London, England)|September 8, 2019
Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort studyGilles R Dagenais, Darryl P Leong, Sumathy Rangarajan, et al.
Eclinicalmedicine|February 2, 2022
Variations in the financial impact of the COVID-19 pandemic across 5 continents: A cross-sectional, individual level analysisAditya K Khetan, Salim Yusuf, Patricio Lopez-Jaramillo, et al.
Lancet (London, England)|September 3, 2017
Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort studyMahshid Dehghan, Andrew Mente, Xiaohe Zhang, et al.
Pageof 53

Showing results (511-520 of 529) with videos related to

Sort By:
Pageof 53
The New England Journal of Medicine|March 28, 2007
Optimal medical therapy with or without PCI for stable coronary diseaseWilliam E Boden, Robert A O'Rourke, Koon K Teo, et al.
Biochimica Et Biophysica Acta. Biomembranes|June 1, 2019
SMA-PAGE: A new method to examine complexes of membrane proteins using SMALP nano-encapsulation and native gel electrophoresisNaomi L Pollock, Megha Rai, Kailene S Simon, et al.
The American Journal of Clinical Nutrition|May 21, 2020
Association of nut intake with risk factors, cardiovascular disease, and mortality in 16 countries from 5 continents: analysis from the Prospective Urban and Rural Epidemiology (PURE) studyRussell J de Souza, Mahshid Dehghan, Andrew Mente, et al.
Circulation|February 13, 2008
Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudyLeslee J Shaw, Daniel S Berman, David J Maron, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 23, 2016
Reference ranges of handgrip strength from 125,462 healthy adults in 21 countries: a prospective urban rural epidemiologic (PURE) studyDarryl P Leong, Koon K Teo, Sumathy Rangarajan, et al.
Journal of the American College of Cardiology|March 27, 2010
Intensive multifactorial intervention for stable coronary artery disease: optimal medical therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trialDavid J Maron, William E Boden, Robert A O'Rourke, et al.
International Journal of Epidemiology|December 23, 2021
Variations in the association of height with mortality, cardiovascular disease and cancer in low-, middle- and high-income countriesAditya K Khetan, Darryl P Leong, Rajeev Gupta, et al.
Lancet (London, England)|September 8, 2019
Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort studyGilles R Dagenais, Darryl P Leong, Sumathy Rangarajan, et al.
Eclinicalmedicine|February 2, 2022
Variations in the financial impact of the COVID-19 pandemic across 5 continents: A cross-sectional, individual level analysisAditya K Khetan, Salim Yusuf, Patricio Lopez-Jaramillo, et al.
Lancet (London, England)|September 3, 2017
Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort studyMahshid Dehghan, Andrew Mente, Xiaohe Zhang, et al.
Pageof 53